News
Microsoft added a bunch of useful capabilities to Excel this month, including one that was highly requested by customers.
BioXcel's Phase 3 trial shows BXCL501 safely reduces agitation in schizophrenia patients, supporting plans for an FDA label ...
6d
Zacks Investment Research on MSNCan Label Expansion of Cabometyx Fuel Further Growth for EXEL?
Exelixis’ (EXEL) lead drug, Cabometyx, a tyrosine kinase inhibitor (TKI), is one of the leading drugs for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results